CELL THERAPEUTICS AS WELL AS ARIAD PHARMA FACE CHALLENGING APPROVAL PROCESSES

SOURCE: The Bedford Report Feb 17, 2011 08:46 ET NEW YORK, NY�(Marketwire � Feb 17, 2011) � there is copiousness of confidence surrounding a Biotech courtesy as firmer pricing as well as latest products have softened sales as well as benefit trends. meanwhile, younger, more suppositional biotech firms such as Cell Therapeutics as well as Ariad Pharmaceuticals go upon to hoard poignant